T1	SNP 42 51	rs2046210
T2	Entity 60 66	6q25.1
R1	SNP_location Arg1:T1 Arg2:T2	
T3	Cancer 77 90	breast cancer
T4	Association 0 11	Association
E1	Association:T4 snp_int:T1 bc:T3
T5	SNP 146 155	rs2046210
T6	Entity 261 267	6q25.1
T7	Entity 288 295	C6orf97
R2	SNP_location Arg1:T5 Arg2:T7	
R3	SNP_location Arg1:T5 Arg2:T6	
T8	Entity 321 325	ESR1
R4	SNP_location Arg1:T5 Arg2:T8	
T9	Entity 224 237	Chinese women
T10	SNP 608 617	rs2046210
T11	Spec 690 703	meta-analysis
T12	Association 587 599	relationship
E2	Association:T12 snp_int:T10 bc:T13
R6	Speculation_marker Arg1:E2 Arg2:T11	
T13	Cancer 638 651	breast cancer
R7	Equiv Arg1:T5 Arg2:T10	
T14	Level 790 801	significant
T15	Effect_Type 802 811	increased
T16	Association 812 816	risk
E3	Association:T16 snp_int:T18 bc:T19
R8	Effect_type_marker Arg1:E3 Arg2:T15	
R9	Level_marker Arg1:E3 Arg2:T14	
A1	Effect_Type E3 Increase
A2	Level E3 High
T17	Entity 829 837	A allele
T18	SNP 841 850	rs2046210
R10	SNP_allele Arg1:T18 Arg2:T17	
T19	Cancer 855 868	breast cancer
R11	Member Arg1:T5 Arg2:T18	
T20	Entity 886 902	total population
R5	Population_assignment Arg1:T18 Arg2:T20	
T21	Level 1154 1165	significant
T22	Effect_Type 1166 1174	elevated
T23	Association 1175 1179	risk
E4	Association:T23 bc:T19 snp_int:T26
A3	Effect_Type E4 Increase
A4	Level E4 High
R12	Effect_type_marker Arg1:E4 Arg2:T22	
R13	Level_marker Arg1:E4 Arg2:T21	
T24	Entity 1196 1205	Europeans
T25	Entity 1210 1216	Asians
T26	SNP 841 850	rs2046210
R14	Population_assignment Arg1:T26 Arg2:T24	
R15	Population_assignment Arg1:T26 Arg2:T25	
R16	SNP_allele Arg1:T26 Arg2:T17	
R17	Member Arg1:T5 Arg2:T26	
T27	Level 1227 1241	no significant
T28	Association 1242 1253	association
E5	Association:T28 bc:T19 snp_int:T30
A5	Level E5 Low
R18	Level_marker Arg1:E5 Arg2:T27	
T29	Entity 1270 1296	African descent population
T30	SNP 841 850	rs2046210
R19	SNP_allele Arg1:T30 Arg2:T17	
R20	Population_assignment Arg1:T30 Arg2:T29	
R21	Member Arg1:T5 Arg2:T30	
R22	Equiv Arg1:T1 Arg2:T5	
T31	SNP 1412 1429	this polymorphism
T32	Effect_Type 1440 1448	increase
T33	Cancer 1449 1462;1471 1482	breast cancer ER negative
T34	Association 1463 1467	risk
E6	Association:T34 bc:T33 snp_int:T31
A6	Effect_Type E6 Increase
R23	Effect_type_marker Arg1:E6 Arg2:T32	
T35	Spec 1397 1406	suggested
R24	Speculation_marker Arg1:E6 Arg2:T35	
T36	Entity 1471 1473	ER
T37	Neg 1474 1482	negative
A7	Cancer_Type T33 ER-
T38	Level 1495 1512	greater magnitude
R25	Level_marker Arg1:E6 Arg2:T38	
A8	Level E6 High
T39	Cancer 1449 1462;1525 1536	breast cancer ER positive
A9	Cancer_Type T39 ER+
E7	Association:T34 bc:T39 snp_int:T31
A10	Effect_Type E7 Increase
T41	Organic_inorganic_molecules_affected 1471 1489	ER negative tumors
E8	Organic_inorganic_molecules_affected:T41 Theme:T36 Agent:T31
R26	Negation_marker Arg1:E8 Arg2:T37	
R27	Speculation_marker Arg1:E8 Arg2:T35	
R28	Level_marker Arg1:E8 Arg2:T38	
A11	Level E8 High
T42	Organic_inorganic_molecules_affected 1525 1543	ER positive tumors
E9	Organic_inorganic_molecules_affected:T42 Agent:T31 Theme:T40
R29	Speculation_marker Arg1:E9 Arg2:T35	
T40	Entity 1525 1527	ER
T43	Effect_Type 1528 1536	positive
R30	Effect_type_marker Arg1:E9 Arg2:T43	
A12	Effect_Type E9 Increase
R31	Speculation_marker Arg1:E7 Arg2:T35	
R32	Equiv Arg1:T10 Arg2:T31	
T44	SNP 1600 1608	this SNP
T45	Level 1613 1626	significantly
T46	Association 1627 1637	associated
E10	Association:T46 snp_int:T44 bc:T47
A13	Level E10 High
R34	Level_marker Arg1:E10 Arg2:T45	
T47	Cancer 1655 1668	breast cancer
T48	Entity 1673 1696	BRCA1 mutation carriers
R33	Risk_Factor Arg1:T44 Arg2:T48	
T49	SNP 1600 1608	this SNP
T50	Level 1711 1717	weaker
T51	Association 1718 1729	association
E11	Association:T51 bc:T47 snp_int:T49
A14	Level E11 Low
R35	Level_marker Arg1:E11 Arg2:T50	
T52	Entity 1748 1771	BRCA2 mutation carriers
R36	Risk_Factor Arg1:T49 Arg2:T52	
T53	SNP 1962 1971	rs2046210
T54	SNP 1962 1971	rs2046210
T55	SNP 1962 1971	rs2046210
R37	Equiv Arg1:T44 Arg2:T54	
R38	Equiv Arg1:T49 Arg2:T55	
T56	Spec 1985 1991	may be
T57	Association 2006 2016	associated
E12	Association:T57 bc:T59 snp_int:T53
T58	Effect_Type 2022 2031	increased
T59	Cancer 2032 2045	breast cancer
A15	Effect_Type E12 Increase
R39	Effect_type_marker Arg1:E12 Arg2:T58	
R40	Speculation_marker Arg1:E12 Arg2:T56	
